InhaleRx Limited (IRX.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.2 Million AUD | 7877.51% |
| 2022 | 15.09 Thousand AUD | -71.01% |
| 2021 | 52.06 Thousand AUD | 297.01% |
| 2020 | -26.42 Thousand AUD | 95.41% |
| 2019 | -576.05 Thousand AUD | 40.69% |
| 2018 | -971.18 Thousand AUD | 24.02% |
| 2017 | -1.27 Million AUD | -143559.15% |
| 2016 | 891.00 AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 60.69 Thousand AUD | -84.15% |
| 2024 Q2 | 60.69 Thousand AUD | 0.0% |
| 2023 Q2 | 219.11 Thousand AUD | 0.0% |
| 2023 Q1 | 219.11 Thousand AUD | 290.65% |
| 2023 FY | 1.2 Million AUD | 7877.51% |
| 2023 Q4 | 382.9 Thousand AUD | 0.0% |
| 2023 Q3 | 382.9 Thousand AUD | 74.75% |
| 2022 FY | 15.09 Thousand AUD | -71.01% |
| 2022 Q4 | -114.93 Thousand AUD | 9.74% |
| 2022 Q2 | -521.00 AUD | 0.0% |
| 2022 Q1 | - AUD | 100.0% |
| 2022 Q3 | -127.33 Thousand AUD | -24340.31% |
| 2021 FY | 52.06 Thousand AUD | 297.01% |
| 2021 Q4 | -72.21 Thousand AUD | -329.86% |
| 2021 Q1 | 1836.00 AUD | 100.95% |
| 2021 Q2 | 1573.00 AUD | -14.32% |
| 2021 Q3 | 31.41 Thousand AUD | 1897.33% |
| 2020 FY | -26.42 Thousand AUD | 95.41% |
| 2020 Q4 | -193.35 Thousand AUD | -157.69% |
| 2020 Q1 | 1609.00 AUD | 100.57% |
| 2020 Q2 | -24.71 Thousand AUD | -1636.3% |
| 2020 Q3 | -75.03 Thousand AUD | -203.54% |
| 2019 Q2 | -300.28 Thousand AUD | -5534.09% |
| 2019 Q1 | 5526.00 AUD | -75.92% |
| 2019 Q3 | -24.85 Thousand AUD | 91.72% |
| 2019 FY | -576.05 Thousand AUD | 40.69% |
| 2019 Q4 | -284.09 Thousand AUD | -1042.98% |
| 2018 Q1 | 64.32 Thousand AUD | -41.15% |
| 2018 FY | -971.18 Thousand AUD | 24.02% |
| 2018 Q4 | 22.94 Thousand AUD | 0.0% |
| 2018 Q3 | 22.94 Thousand AUD | -64.33% |
| 2018 Q2 | 64.32 Thousand AUD | 0.0% |
| 2017 Q2 | 25.63 Thousand AUD | 0.0% |
| 2017 Q4 | 109.29 Thousand AUD | 0.0% |
| 2017 FY | -1.27 Million AUD | -143559.15% |
| 2017 Q1 | 25.63 Thousand AUD | 0.0% |
| 2017 Q3 | 109.29 Thousand AUD | 326.43% |
| 2016 FY | 891.00 AUD | 0.0% |
| 2016 Q2 | 228.00 AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | 65.77% |
| Adherium Limited | -640.83 Thousand AUD | 287.887% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 97.77% |
| Atomo Diagnostics Limited | 1.43 Million AUD | 16.194% |
| Anteris Technologies Ltd | 2.51 Million AUD | 52.167% |
| Control Bionics Limited | 3.67 Million AUD | 67.217% |
| CardieX Limited | 10.1 Million AUD | 88.088% |
| Compumedics Limited | 26.06 Million AUD | 95.381% |
| Cochlear Limited | 1.69 Billion AUD | 99.929% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 89.4% |
| Cyclopharm Limited | 4.49 Million AUD | 73.228% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 89.268% |
| Nova Eye Medical Limited | 20.19 Million AUD | 94.037% |
| HeraMED Limited | -504.09 Thousand AUD | 338.853% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 160.417% |
| ImpediMed Limited | 9 Million AUD | 86.629% |
| LBT Innovations Limited | -2.91 Million AUD | 141.277% |
| Micro-X Limited | 5.73 Million AUD | 79.013% |
| Neurotech International Limited | -5867.00 AUD | 20622.345% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -2064.305% |
| PolyNovo Limited | 36.08 Million AUD | 96.663% |
| Respiri Limited | 456.91 Thousand AUD | -163.517% |
| SomnoMed Limited | 55.13 Million AUD | 97.816% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 71.9% |
| Uscom Limited | 3.11 Million AUD | 61.355% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 544.107% |